Andere Kunden interessierten sich auch für
![Seroprävalenz des Humanen Papillomavirus bei schwangeren Frauen]( "Seroprävalenz des Humanen Papillomavirus bei schwangeren Frauen")
Seroprävalenz des Humanen Papillomavirus bei schwangeren Frauen54,90 €![Factors Associated with Gender-based Violence among Pregnant Women]( "Factors Associated with Gender-based Violence among Pregnant Women")
Factors Associated with Gender-based Violence among Pregnant Women32,99 €![Health education modules on malaria prevention for pregnant women]( "Health education modules on malaria prevention for pregnant women")
Health education modules on malaria prevention for pregnant women26,99 €![Anemia Status and Associated Factors among Pregnant Women]( "Anemia Status and Associated Factors among Pregnant Women")
Anemia Status and Associated Factors among Pregnant Women36,99 €![Seroprevalence of HIV infection in pregnant women in Amassoma, Nigeria]( "Seroprevalence of HIV infection in pregnant women in Amassoma, Nigeria")
Seroprevalence of HIV infection in pregnant women in Amassoma, Nigeria32,99 €![Vaginal Infection in Pregnant Women]( "Vaginal Infection in Pregnant Women")
Vaginal Infection in Pregnant Women26,99 €![Human papillomavirus and its relationship to cervical cancer]( "Human papillomavirus and its relationship to cervical cancer")
Human papillomavirus and its relationship to cervical cancer29,99 €
Human papillomavirus (HPV) infection among pregnant women attending antenatal clinic in Barau Dikko teaching Hospital Kaduna was evaluated. Papillomaviruses are double-stranded DNA viruses that constitute the Papillomavirus genus of the Papillomaviridae family. These viruses are highly species specific and infect only humans. The study was aimed at determining the prevalence of HPV infection and the level of anti HPV-IgG antibody in pregnant women. The sampled subjects were eighty one (81) pregnant women attending antenatal clinic in Barau Dikko teaching hospital Kaduna. The sample size was determined by standard statistical formula with confidence level at 95% and margin of error at 5% respectively (Ramachandran, 2012). This assessment is essential for effective planning of HPV vaccine implementation into preventive and monitoring programmes.